Found "AI": 1,091 results
Sort by
Z - A

Which investment on interventions against COVID-19 pandemic is worth its cost?

Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted

When is a SEED Good for Health and Money at the National Level?

Investment is the seed of economic progress. Wherever it is planted in an appropriate way, it grows and gives us incalculable benefits. Health intervention and technology are the same for national health improvement. They promote citizen’s quality of life and longevity. But how do we know which medi

WHAT’S IN, WHAT’S OUT? Designing Benefits for Universal Health Coverage

Healthcare systems in low- and middle-income countries are undergoing major changes. Countries are growing richer and losing aid eligibility, and disease burdens are shifting to noncommunicable chronic diseases. Technological and knowledge breakthroughs mean more and more of a country’s disease burd

What the Role of HTA in Healthcare Systems should be after COVID-19?

The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the

What is the value of explicit priority setting for health interventions? A simulation study

Abstract Many countries seek to secure efficiency in health spending through establishing explicit priority setting institutions (PSIs). Since such institutions divert resources from frontline services which benefit patients directly, it is legitimate and reasonable to ask whether they are worth

What is the value of a Quality-Adjusted Life Year and How Much Is It ?

The value of a Quality-Adjusted Life Year (QALY) used to screen medicines for inclusion in the National List of Essential Medicines (NLEM) in 2013 was 160,000 baht per QALY. Any medicines that cost less than this amount is considered to be cost-effective. However, is this figure consistent with publ

What do you think about COVID-19 vaccination certificates for international travel?

What do you think about COVID-19 vaccination certificates for international travel? This survey on COVID-19 vaccination certificates is part of a regional research study from the COVID-19 vaccination policy research and decision-support initiative in Asia (CORESIA). We would like

What criteria do decision makers in Thailand use to set priorities for vaccine introduction? (2016)

Siriporn Pooripussarakul1, Arthorn Riewpaiboon1* , David Bishai2, Charung Muangchana3 and Sripen Tantivess4 Abstract Background: There is a need to identify rational criteria and set priorities for vaccines. In Thailand, many licensed vaccines are being considering for introduction into the Ex

What could India’s HTA mechanism for its healthcare system look like?

With HTA gaining ground as a tool for priority-setting globally, it comes as no surprise that, alongside many other questions on the development of the mechanism, countries are trying to find ways to adapt HTA to their particular healthcare system and context. Such was the case the HITAP team found

What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN?; Comment on “Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks”

The coronavirus disease 2019 (COVID-19) pandemic has brought the need for regional collaboration on disease prevention and control to the fore. The review by Durrance-Bagale et al offers insights on the enablers, barriers and lessons learned from the experience of various regional initiatives. Trans
10 / Page